Patent ID: 8278417

Claim:
A kit for use in a method for healing a wound comprising packaging material, an extraembryonic cell-derived cellular cytokine solution composition comprising physiologic concentrations of VEGF, TGFβ2, Angiogenin, PDGF, TIMP-1 and TIMP-2, wherein the physiologic concentration is ˜5.0-16 ng/mL for VEGF, ˜3.5-4.5 ng/mL for Angiogenin, ˜100-165 pg/mL for PDGF, ˜2.5-2.7 ng/mL for TGFβ2, ˜0.68 μg mL for TIMP-1 and ˜1.04 μg/mL for TIMP-2, and instructions for the use of the composition to heal a wound, wherein the wound is selected from the group consisting of a surgical incision of the skin or fascia, an ulcer on the skin or a mucous membrane, and a burn.